These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3827466)

  • 1. Association of primary hyperparathyroidism with myotonic dystrophy in two patients.
    Harada S; Matsumoto T; Ikeda K; Fukumoto S; Ihara Y; Ogata E
    Arch Intern Med; 1987 Apr; 147(4):777-8. PubMed ID: 3827466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperparathyroidism in patients with myotonic dystrophy.
    Yoshida H; Oshima H; Saito E; Kinoshita M
    J Clin Endocrinol Metab; 1988 Sep; 67(3):488-92. PubMed ID: 2842360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between myotonic dystrophy and primary hyperparathyroidism.
    Bell E; Lorimer AR; Hinnie J
    J Int Med Res; 1994; 22(5):296-8. PubMed ID: 7867876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Respiratory failure: respiratory disorder during sleep in patients with myotonic dystrophy].
    Takasugi T; Ishihara T; Kawamura J; Kawashiro T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1486-8. PubMed ID: 8752439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hyperthyroidism and associated hyperparathyroidism in a patient with myotonic dystrophy: Steinert with hyperthyroidism and hyperparathyroidism.
    Molina MJ; Lara JI; Riobo P; Guijarro S; Moreno A; Del Peso C; Gonzalo A; Rovira A; Herrera-Pombo JL
    Am J Med Sci; 1996 Jun; 311(6):296-8. PubMed ID: 8659558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical therapy concept in primary hyperparathyroidism].
    Rusterholz D; Müller W
    Schweiz Med Wochenschr Suppl; 2000; 116():62S-65S. PubMed ID: 10780075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal calcium metabolism in myotonic dystrophy (II): Increased level of nephrogenous cyclic AMP and serum immunoreactive parathyroid hormone].
    Yoshida H; Kinoshita M; Oshima H; Saito E
    Nihon Naibunpi Gakkai Zasshi; 1988 Jul; 64(7):539-46. PubMed ID: 2851465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hyperparathyroidism: do perioperative biochemical variables correlate with parathyroid adenoma weight or volume?
    Randhawa PS; Mace AD; Nouraei SA; Stearns MP
    Clin Otolaryngol; 2007 Jun; 32(3):179-84. PubMed ID: 17550505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
    Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there any connection between the presence of kidney stones in primary hyperparathyroidism and the location of an underlying adenoma?
    Csupor E; Toth E; Meszaros S; Ferencz V; Szucs J; Lakatos P; Horányi J; Perner F; Horvath C
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):257-61. PubMed ID: 15926110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological fracture: a common presentation of primary hyperparathyroidism in Iraq.
    Sawa TE; Safar SB
    Eur J Surg; 1996 Oct; 162(10):777-81. PubMed ID: 8934106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IgG subclasses in the patients with myotonic dystrophy].
    Sofue F; Suzumura A; Yamamoto H
    Rinsho Shinkeigaku; 1994 Aug; 34(8):788-92. PubMed ID: 7994985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
    Berczi C; Balogh A; Balázs G; Lukács G
    Orv Hetil; 2002 Mar; 143(12):597-600. PubMed ID: 11963396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormal calcium metabolism in myotonic dystrophy: increased level of serum 1,25(OH)2D concentration and augmented intestinal calcium absorption].
    Oshima H; Kinoshita M; Yoshida H; Saito E
    Nihon Naibunpi Gakkai Zasshi; 1986 Oct; 62(10):1203-11. PubMed ID: 3803629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy.
    Awad SS; Miskulin J; Thompson N
    World J Surg; 2003 Apr; 27(4):486-8. PubMed ID: 12658498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hyperparathyroidism: incidence and clinical and biochemical characteristics. A demographic study.
    Mollerup CL; Bollerslev J; Blichert-Toft M
    Eur J Surg; 1994 Sep; 160(9):485-9. PubMed ID: 7849167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe neurological disease associated with hyperparathyroidism.
    Patten BM; Pages M
    Ann Neurol; 1984 May; 15(5):453-6. PubMed ID: 6732192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrinological characteristic of primary hyperparathyroidism].
    Kohri K
    Hinyokika Kiyo; 1984 Jul; 30(7):981-4. PubMed ID: 6095627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperparathyroidism and heart disease--a review.
    Andersson P; Rydberg E; Willenheimer R
    Eur Heart J; 2004 Oct; 25(20):1776-87. PubMed ID: 15474692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.